Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Scientific Reports|April 5, 2024
Risk factors for liver dysfunction and their clinical importance after gastric cancer surgeryShutaro Sumiyoshi, Takeshi Kubota, Takuma Ohashi, et al.
Surgery Today|July 16, 2021
The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resectionHirotaka Furuke, Tomohiro Arita, Yoshiaki Kuriu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Optimal Lymph Node Dissection and Prognosis for Primary Small Bowel Adenocarcinoma]Kaho Owada, Jun Kiuchi, Tomohiro Arita, et al.
Oncology Letters|November 11, 2024
Patients with T4N0 and T1‑3N1 colon cancer and a high preoperative carcinoembryonic antigen level benefit from adjuvant chemotherapy with oxaliplatin for 6 monthsHiroyuki Inoue, Hiroki Shimizu, Yoshiaki Kuriu, et al.
Scientific Reports|February 24, 2025
Re-examining the optimal extent of lymph node dissection for colon cancer using the lymphadenectomy indexYuta Marunaka, Jun Kiuchi, Yoshiaki Kuriu, et al.
Oncotarget|October 18, 2019
Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junctionKenichi Aratani, Shuhei Komatsu, Daisuke Ichikawa, et al.
Anticancer Research|July 5, 2022
The Role of Inflammation-associated microRNA-4257 as a Promoter of Malignancy in Colorectal CancerSatoshi Kataoka, Tomohiro Arita, Hirotaka Konishi, et al.
Asian Journal of Endoscopic Surgery|May 4, 2026
Tri-Scenario-Based MAICOHAN Strategy for Minimally Invasive Extended Left HepatectomyYusuke Yamamoto, Ryo Morimura, Taisuke Imamura, et al.
Anticancer Research|May 29, 2017
Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric JunctionKenichi Aratani, Shuhei Komatsu, Daisuke Ichikawa, et al.
Scientific Reports|July 20, 2017
Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancerTaisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, et al.
Pageof 9